Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Epidemiology and resistance patterns in urinary pathogens from long-term care facilities and GP populations.

Brabazon E, Carton M, Dornikova G, Bedford D.

Ir Med J. 2012 Jun;105(6):177-80.

PMID:
22973655
2.

The changing pattern of antimicrobial resistance within 42,033 Escherichia coli isolates from nosocomial, community and urology patient-specific urinary tract infections, Dublin, 1999-2009.

Cullen IM, Manecksha RP, McCullagh E, Ahmad S, O'Kelly F, Flynn RJ, McDermott T, Murphy P, Grainger R, Fennell JP, Thornhill JA.

BJU Int. 2012 Apr;109(8):1198-206. doi: 10.1111/j.1464-410X.2011.10528.x. Epub 2011 Aug 24.

3.

Antimicrobial resistance in E.coli associated with urinary tract infection in the west of Ireland.

Chulain MN, Murray AM, Corbett-Feeney G, Cormican M.

Ir J Med Sci. 2005 Oct-Dec;174(4):6-9.

PMID:
16445153
4.
6.

Antibiotic resistance in outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA).

Zhanel GG, Hisanaga TL, Laing NM, DeCorby MR, Nichol KA, Palatnik LP, Johnson J, Noreddin A, Harding GK, Nicolle LE, Hoban DJ; NAUTICA Group.

Int J Antimicrob Agents. 2005 Nov;26(5):380-8.

PMID:
16243229
7.

Consensus review of the epidemiology and appropriate antimicrobial therapy of complicated urinary tract infections in Asia-Pacific region.

Hsueh PR, Hoban DJ, Carmeli Y, Chen SY, Desikan S, Alejandria M, Ko WC, Binh TQ.

J Infect. 2011 Aug;63(2):114-23. doi: 10.1016/j.jinf.2011.05.015. Epub 2011 Jun 12. Review.

PMID:
21669223
8.

Antimicrobial resistance patterns of urinary tract pathogens and rationale for empirical therapy in Turkish children for the years 2000-2006.

Catal F, Bavbek N, Bayrak O, Karabel M, Karabel D, Odemis E, Uz E.

Int Urol Nephrol. 2009 Dec;41(4):953-7. doi: 10.1007/s11255-008-9445-5. Epub 2008 Aug 14.

PMID:
18704743
9.

Antibiotic resistance of urinary tract pathogens and evaluation of empirical treatment in Turkish children with urinary tract infections.

Yüksel S, Oztürk B, Kavaz A, Ozçakar ZB, Acar B, Güriz H, Aysev D, Ekim M, Yalçinkaya F.

Int J Antimicrob Agents. 2006 Nov;28(5):413-6. Epub 2006 Sep 26.

PMID:
17000085
10.

Extended-spectrum β-lactamase-producing Gram-negative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapy.

Meier S, Weber R, Zbinden R, Ruef C, Hasse B.

Infection. 2011 Aug;39(4):333-40. doi: 10.1007/s15010-011-0132-6. Epub 2011 Jun 25.

PMID:
21706226
12.

Increased rates of trimethoprim resistance in uncomplicated urinary tract infection: cause for concern?

Mangin D, Toop L, Chambers S, Ikram R, Harris B.

N Z Med J. 2005 Nov 11;118(1225):U1726.

PMID:
16286940
13.

Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.

Arslan H, Azap OK, Ergönül O, Timurkaynak F; Urinary Tract Infection Study Group.

J Antimicrob Chemother. 2005 Nov;56(5):914-8. Epub 2005 Sep 20.

PMID:
16174685
14.

Factors associated with antibiotic resistance in coliform organisms from community urinary tract infection in Wales.

Howard AJ, Magee JT, Fitzgerald KA, Dunstan FD; Welsh Antibiotic Study Group.

J Antimicrob Chemother. 2001 Mar;47(3):305-13.

PMID:
11222563
15.

A multilevel analysis of trimethoprim and ciprofloxacin prescribing and resistance of uropathogenic Escherichia coli in general practice.

Vellinga A, Murphy AW, Hanahoe B, Bennett K, Cormican M.

J Antimicrob Chemother. 2010 Jul;65(7):1514-20. doi: 10.1093/jac/dkq149. Epub 2010 May 10.

PMID:
20457673
16.
17.
18.
19.

Increasing ciprofloxacin resistance among prevalent urinary tract bacterial isolates in Bangladesh.

Iqbal J, Rahman M, Kabir MS, Rahman M.

Jpn J Med Sci Biol. 1997 Dec;50(6):241-50.

PMID:
9789787

Supplemental Content

Support Center